M Mabry

1.7k total citations
26 papers, 1.5k citations indexed

About

M Mabry is a scholar working on Oncology, Molecular Biology and Epidemiology. According to data from OpenAlex, M Mabry has authored 26 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Oncology, 10 papers in Molecular Biology and 8 papers in Epidemiology. Recurrent topics in M Mabry's work include Lung Cancer Research Studies (11 papers), Neuroendocrine Tumor Research Advances (8 papers) and Neuroblastoma Research and Treatments (5 papers). M Mabry is often cited by papers focused on Lung Cancer Research Studies (11 papers), Neuroendocrine Tumor Research Advances (8 papers) and Neuroblastoma Research and Treatments (5 papers). M Mabry collaborates with scholars based in United States, Denmark and Switzerland. M Mabry's co-authors include Stephen B. Baylin, Edward Gabrielson, R T Vollmer, David Sidransky, Adrian Merlo, Barry D. Nelkin, Takeshi Nakagawa, Samuel D. Bernal, S B Baylin and Rolf A. Stahel and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and Journal of Clinical Oncology.

In The Last Decade

M Mabry

25 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M Mabry United States 18 835 667 284 266 232 26 1.5k
Yuzo Furuya Japan 22 923 1.1× 510 0.8× 731 2.6× 359 1.3× 113 0.5× 83 1.9k
Cataldo Bianco Italy 24 757 0.9× 765 1.1× 427 1.5× 252 0.9× 110 0.5× 37 1.5k
Neyaz Alam India 21 962 1.2× 362 0.5× 387 1.4× 381 1.4× 154 0.7× 56 1.4k
Patrick J. Grohar United States 19 1.1k 1.3× 444 0.7× 623 2.2× 234 0.9× 246 1.1× 45 1.7k
Isabel Chu United States 11 1.1k 1.4× 1.0k 1.5× 213 0.8× 346 1.3× 94 0.4× 12 1.8k
B. F. El-Rayes United States 19 348 0.4× 615 0.9× 385 1.4× 220 0.8× 98 0.4× 38 1.2k
Roberto E. Favoni Italy 20 844 1.0× 541 0.8× 356 1.3× 327 1.2× 91 0.4× 39 1.6k
Yan Cai China 16 674 0.8× 301 0.5× 196 0.7× 306 1.2× 93 0.4× 40 1.0k
Takatomo Koshiba Japan 16 658 0.8× 856 1.3× 99 0.3× 318 1.2× 67 0.3× 29 1.5k
Elisabeth E. Bond United States 9 1.5k 1.8× 1.3k 2.0× 152 0.5× 487 1.8× 137 0.6× 15 2.1k

Countries citing papers authored by M Mabry

Since Specialization
Citations

This map shows the geographic impact of M Mabry's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M Mabry with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M Mabry more than expected).

Fields of papers citing papers by M Mabry

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M Mabry. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M Mabry. The network helps show where M Mabry may publish in the future.

Co-authorship network of co-authors of M Mabry

This figure shows the co-authorship network connecting the top 25 collaborators of M Mabry. A scholar is included among the top collaborators of M Mabry based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M Mabry. M Mabry is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Lima, Caio Max S. Rocha, Herbert I. Hurwitz, Alberto J. Montero, et al.. (2011). Combination study of navitoclax with gemcitabine (G) in patients (pts) with solid tumors.. Journal of Clinical Oncology. 29(15_suppl). 3067–3067. 1 indexed citations
3.
Blumenschein, G. R., Fadlo R. Khuri, U. Gatzemeier, et al.. (2005). A randomized phase III trial comparing bexarotene/carboplatin/paclitaxel versus carboplatin/paclitaxel in chemotherapy-naive patients with advanced or metastatic non-small cell lung cancer (NSCLC). Journal of Clinical Oncology. 23(16_suppl). LBA7001–LBA7001. 24 indexed citations
4.
Ravi, Rajani, Erich Weber, Martin McMahon, et al.. (1998). Activated Raf-1 causes growth arrest in human small cell lung cancer cells.. Journal of Clinical Investigation. 101(1). 153–159. 125 indexed citations
5.
Ravi, Rajani, Frank Scott, F. Cuttitta, et al.. (1998). Induction of gastrin releasing peptide by all-trans retinoic acid in small cell lung cancer cells.. Oncology Reports. 5(2). 497–501. 9 indexed citations
6.
Tucker, Margaret A., Nevin Murray, Edward G. Shaw, et al.. (1997). Second Primary Cancers Related to Smoking and Treatment of Small-Cell Lung Cancer. JNCI Journal of the National Cancer Institute. 89(23). 1782–1788. 167 indexed citations
7.
Bunn, P. A., Cynthia K. Harris, K. Havemann, et al.. (1997). Fifth I.A.S.L.C. Lung Tumor Biology Workshop, August 13–17, 1996, Ermatingen, Switzerland. Annals of Oncology. 8(1). 27–36. 1 indexed citations
8.
Bunn, Paul A., David P. Carbone, Curtis C. Harris, et al.. (1997). 5th I.A.S.L.C. Lung Tumor Biology Workshop, August 13–17, 1996, Ermatingen, Switzerland. Lung Cancer. 16(2-3). 239–257. 1 indexed citations
9.
Weber, Erich, Doris Schmitter, Jürg A. Zarn, et al.. (1995). Radiation Studies on B Cell Differentiation Marker CD24/SCLC Cluster-4 Antigen Expressing and Non-expressing Lung Cancer Cell Lines and Mouse Fibroblasts. International Journal of Radiation Biology. 68(2). 205–213. 5 indexed citations
10.
Kalemkerian, Gregory P., et al.. (1995). Growth Inhibition and Induction of Apoptosis by Fenretinide in Small-Cell Lung Cancer Cell Lines. JNCI Journal of the National Cancer Institute. 87(22). 1674–1680. 88 indexed citations
11.
Merlo, Adrian, M Mabry, Edward Gabrielson, et al.. (1994). Frequent microsatellite instability in primary small cell lung cancer.. PubMed. 54(8). 2098–101. 196 indexed citations
12.
Merlo, Adrian, Edward Gabrielson, M Mabry, et al.. (1994). Homozygous deletion on chromosome 9p and loss of heterozygosity on 9q, 6p, and 6q in primary human small cell lung cancer. Lung Cancer. 11(5-6). 428–428. 85 indexed citations
13.
Penno, Margaret B., J. Thomas August, S B Baylin, et al.. (1994). Expression of CD44 in human lung tumors. Lung Cancer. 11(5-6). 431–431. 146 indexed citations
14.
Malkinson, Alvin M., David Siegel, Gerald L. Forrest, et al.. (1993). Elevated DT-diaphorase activity and messenger RNA content in human non-small cell lung carcinoma: Relationship to the response of lung tumor xenografts to mitomycin C. Lung Cancer. 10(1-2). 141–141. 151 indexed citations
15.
Mabry, M, et al.. (1991). c-myc gene-induced alterations in protein kinase C expression: a possible mechanism facilitating myc-ras gene complementation.. PubMed. 51(20). 5514–9. 22 indexed citations
16.
Doyle, L. Austin, M Mabry, R. Stahel, Robert Waibel, & Laura H. Goldstein. (1991). Modulation of neuroendocrine surface antigens in oncogene-activated small cell lung cancer lines. Lung Cancer. 7(6). 390–390. 3 indexed citations
17.
Falco, Joseph, S B Baylin, Ruth Lupu, et al.. (1990). v-rasH induces non-small cell phenotype, with associated growth factors and receptors, in a small cell lung cancer cell line.. Journal of Clinical Investigation. 85(6). 1740–1745. 46 indexed citations
18.
Mabry, M, Takeshi Nakagawa, Stephen B. Baylin, et al.. (1989). Insertion of the v-Ha-ras oncogene induces differentiation of calcitonin-producing human small cell lung cancer.. Journal of Clinical Investigation. 84(1). 194–199. 36 indexed citations
19.
Mabry, M, Takeshi Nakagawa, Barry D. Nelkin, et al.. (1988). v-Ha-ras oncogene insertion: a model for tumor progression of human small cell lung cancer.. Proceedings of the National Academy of Sciences. 85(17). 6523–6527. 56 indexed citations
20.
Nakagawa, Takeshi, M Mabry, A de Bustros, et al.. (1987). Introduction of v-Ha-ras oncogene induces differentiation of cultured human medullary thyroid carcinoma cells.. Proceedings of the National Academy of Sciences. 84(16). 5923–5927. 99 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026